Official UK procurement notice
Aseptically Manipulated or Terminally Sterile Medicinal Products
Authority: Peninsula Purchasing & Supply Alliance
What is being bought6 lots · detail below
Published requirement descriptionThe supply of aseptically manipulated or terminally sterile products to NHS Trusts within the boundaries of the Peninsula Purchasing and Supply Alliance (PPSA). Products include national dose-banded cytotoxic and non-cytotoxic batch and patient specific medicines in ready-to-use infusion bags and pre-filled syringes.
This procurement is being managed by the Peninsula Purchasing and Supply Alliance (hereafter referred to as the PPSA) on behalf of the Royal Devon University Healthcare NHS Foundation Trust (hereafter referred to as the Organisation) acting for itself and for Gloucestershire Hospitals NHS Trust, Great Western Hospitals NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust, Salisbury NHS Foundation Trust, Somerset NHS Foundation Trust, Torbay & South Devon NHS Foundation Trust, University Hospitals Plymouth NHS Trust, North Bristol NHS Trust, University Hospitals Bristol & Weston NHS Foundation Trust and the Royal United Hospital Bath NHS Foundation Trust.
CPV: Infusion solutions · Injectable solutions · Intravenous fluids · Pharmaceutical products · Toxins · Various medicinal products
Lots and requirements (6)Procurement structure
6 lots · 4 with a published value (£81,500,000 together) · same evaluation weights on every lotLot #1Aseptically prepared productsCancelled UK, South WestPublished value£46,000,000
Supply of Cyclophosphamide, Doxorubicin & Pembrolizumab compounded ready-to-use batch and patient-specific products. Additional information: The invitation to tender (ITT) documents and additional information is available from CTM e-procurement portal at uk.eu-supply.com ↗
Tenders or requests to participate must be submitted electronically via the CTM e-procurement portal at uk.eu-supply.com ↗
If not already registered on CTM eu-supply.com you will need to register as a supplier to express interest.
Lot #2Aseptically prepared productsCancelled South WestPublished value£25,000,000
Supply of Carboplatin, Epirubicin, Nivolumab & Paclitaxel.
Lot #3Aseptically Prepared ProductsCancelled South WestPublished value£9,000,000
Supply of Atezolizumab (Tecentriq®), Bortezomib Subcut, Docetaxel, Fluorouracil, Oxaliplatin & Vincristine.
Lot #4Aseptically Prepared Products South WestPublished value£1,500,000
Supply of Bleomycin, Cabazitaxel, Calcium folinate, Cisplatin, Cytarabine, Daunorubicin, Ganciclovir, Suxamethonium & Vinblastine.
Lot #5Aseptically Prepared ProductsCancelled South WestLot estimate not published
Supply of Cytarabine, Daunorubicin, Ganciclovir & Vinblastine.
Lot #6Aseptically Prepared ProductsCancelled South WestLot estimate not published
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (4)
- QA Processes & Service: 30%
- Stability: 15%
- price: 45%
- Social Value: 10%
Published award criteria (4)
- QA Processes & Service: 30%
- Social Value: 10%
- Stability: 15%
- Price: 45%
- Price carries 45 of 100 points: a 10% discount moves about 4.5 points. Quality carries 45 of 100: the paper moves it further than the discount.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- No (one-off requirement)
- First published
- 4 May 2023, 14:09 BST
- Last source update
- 20 Aug 2024, 10:04 BST
- Award evaluation window
- 6 Jun 2023 – …
- Authority reference
T22/0446- FTS notice number
2024/S 000-026414- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03c657Find a Tender
Publisher note: The following Trusts may join any Contract(s) awarded from the Tender at any time during the Contract Period including Dorset County Hospital NHS Foundation Trust, Jersey General Hospital, Princess Elizabeth Hospital, Guernsey and University Hospitals Dorset NHS Foundation Trust.
How it was run
Official notice- Submission deadline
- 13 Jul 2023, 12:00 BST
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bid validity
- 240 days from the deadline
- Bids opened
- 6 Jun 2023, 09:00 BST
Timeline
6 Jun 2023 → 20 Aug 2024 · 3 dates- Bids opened6 Jun 2023, 09:00 BST
- Submission deadline13 Jul 2023, 12:00 BST
- Notice published20 Aug 2024, 10:04 BST
Notice history
3 events · 4 releases on Find a Tender · since 18 May 2023- Deadline moved to 16 Jun 2023, 12:00 BST18 May 2023, 10:09 BST+11 days · was 5 Jun 2023, 14:00 BST
- Deadline moved to 13 Jul 2023, 12:00 BST8 Jun 2023, 15:24 BST+27 days · was 16 Jun 2023, 12:00 BST
- Status changed to complete20 Aug 2024, 10:04 BST
Published amendments (2 · 2 deadline changes)
| When | What | Before | After | Shift |
|---|---|---|---|---|
| — | DeadlineTime limit for receipt of tenders · IV.2.2 | 5 Jun 2023 | 16 Jun 2023 | +11 d |
| — | Bid openingConditions for opening of tenders · IV.2.7 | 6 Jun 2023 | 16 Jun 2023 | +10 d |
| — | DeadlineTime limit for receipt of tenders · IV.2.2 | 16 Jun 2023 | 13 Jul 2023 | +27 d |
| — | Bid openingConditions for opening of tenders · IV.2.7 | 16 Jun 2023 | 13 Jul 2023 | +27 d |
| — | TextDuration of Contract · II.2.7 | Duration of Contract - 48 months | Duration of Contract - 36 months | |
| — | TextDescription of options · II.2.11 | Lot 1 has the option to be extended for any period up to 36 months Lot 2 has the option to be extended for any period up to 36 months Lot 3 has the option to be extended for any period up to 36 months Lot 4 has the option to be extended for any period up to 36 months | Lot 1 has the option to be extended for any period up to 24 months Lot 2 has the option to be extended for any period up to 24 months Lot 3 has the option to be extended for any period up to 24 months Lot 4 has the option to be extended for any period up to 24 months |
2 amendments published without a description.
Routine re-releases (4)
- 2023-05: 1 release · 4 May 2023
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Not linked to a lot5 awards | |||
| Quantum Pharmaceutical Limited | £25,000,000 † | — | Awarded |
| Qualasept Ltd t/a Bath ASU | £13,000,000 † | — | Awarded |
| Quantum Pharmaceutical Limited | £5,000,000 † | — | Awarded |
| Qualasept Ltd t/a Bath ASU | £450,000 † | — | Awarded |
| Quantum Pharmaceutical Limited | £170,000 † | — | Awarded |
Contracts
Lot 1 · Quantum Pharmaceutical Limited
- Signed
- 18 Jun 2024
- Value
- £25,000,000
- Status
- active
Lot 3 · Quantum Pharmaceutical Limited
- Signed
- 18 Jun 2024
- Value
- £5,000,000
- Status
- active
Lot 4b · Quantum Pharmaceutical Limited
- Signed
- 18 Jun 2024
- Value
- £170,000
- Status
- active
Lot 2 · Qualasept Ltd t/a Bath ASU
- Signed
- 24 May 2024
- Value
- £13,000,000
- Status
- active
Lot 4a · Qualasept Ltd t/a Bath ASU
- Signed
- 24 Apr 2024
- Value
- £450,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 3bids · 3 electronic | 0 | — | — |
Contracting authority & participating public bodies
Bidders & participating suppliers
3 commercial parties on the notice- Qualasept Ltd t/a Bath ASUAwarded supplier
- Qualasept Ltd t/a Bath ASUAwarded supplier
- Quantum Pharmaceutical LimitedAwarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria